The logo

Hello guest, welcome to PJ online

gateway to the world of pharmacy and medicines

Citation

  • The Pharmaceutical Journal
  • 2009;
  • 283:
Download PDF

BPC 2009 (supplement)

Tue, 03/11/2009 - 11:49

British Pharmaceutical Conference page

Reports from the British Pharmaceutical Conference (BPC) 2009, by The Pharmaceutical Journal

The supplement is available as a PDF file (1.8 MB)


Leading article

Innovation is the key
This year’s British Pharmaceutical Conference — once again held in Manchester — was something of an innovation. It was divided into two, with the practice sessions starting on Sunday 6 September and the science sessions beginning the day after
PJ 2009;283:B2

President

Society’s President urges profession to unite to create a brighter future
In his address to BPC 2009, the Royal Pharmaceutical Society’s President, Steve Churton, described recent initiatives that demonstrate how the Society has become more member-focused and spoke of the new professional body’s “commitment to pharmacy”
PJ 2009;283:B3-5

Practice Chairman

Why research pharmacy practice?
Drawing on his own research over the past 15 years, BPC Practice Chairman Peter Noyce discusses the nature of pharmacy practice research, the insights it provides, its impact and the challenges faced in terms of its capacity and sustainability
PJ 2009;283:B6-8

Practice sessions

Gareth Malson and Francesca Rivers report on the new regulatory framework and on the work of the Practice Research Conference Award winner

 

Drive for quality and innovation must not be lost during financial challenges
In this session, representatives of the four UK health departments spoke about the importance of quality and innovation to deliver the savings and efficiencies that will be required within the NHS in the financially challenging times ahead. Harriet Adcock reports
PJ 2009;283:B10-11

How remote supervision is being used to benefit patients in Canada
Remotely supervised dispensing machines recently introduced in Ontario, Canada, enable pharmacy services to be extended to people living in remote areas without compromising patient safety, conference participants heard. Gareth Malson reports
PJ 2009;283:B12

 

Benedict Lam reports on the Royal Pharmaceutical Society’s simulated patient project and on the importance of pharmacists in reclassifying drugs

 

Pharmacist prescribers: latest lessons and developments from the field
Beth Taylor, Anne Adams and Zoe Girdis report on a workshop examining the latest developments and research relating to prescribing by pharmacists 
PJ 2009;283:B14

Communication and integration key to successful medicines use reviews
Participants heard how pharmacists are delivering medicines use reviews in practice and how the Royal Pharmaceutical Society’s audit tool can help to demonstrate the quality and benefit of MURs at a national level. Heidi Wright reports
PJ 2009;283:B15

Student wins prize for new prison pharmacist logo
A logo is essential to recognising a particular organisation or specialty. To that end, pharmacists who work in secure establishments recently embarked on finding a suitable logo to identify their group
PJ 2009;283:B15

 

Benedict Lam, Nicola Cree and Francesca Rivers report on progress with NHS Health Checks and on the research poster winners at 2009's British Pharmaceutical Conference

 

Speed dating sessions with specialist and advanced level practitioners
This session, organised by the Royal Pharmaceutical Society’s Community Pharmacists Group, featured pharmacists from community and secondary care who led a speed dating style meeting to describe their experiences of advanced and specialist practice. Nina Barnett reports
PJ 2009;283:B17

 

Gareth Malson and Nicola Cree report on problems in primary care and how pharmacists can reduce adverse drug reactions

 

Innovation central to taking services forward in challenging financial times
Hospital tsar Martin Stephens highlighted how pharmacists can help the NHS to maximise productivity within limited resources. Harriet Adcock reports
PJ 2009;283:B19

 

Practice abstracts

Pharmacy practice research reviewed
One hundred and two practice research papers were presented at the 2009 British Pharmaceutical Conference. Pamela Mason reviews a selection of the most interesting papers, including studies on medicines use reviews, non-prescription medicines, public health and workforce issues
PJ 2009;283:B20-B22

 

Science Chairman

Nanomedicines in sharp focus
Ijeoma Uchegbu describes how nanoparticles can be used advantageously to alter drug biodistribution and unlock the potential of various compounds, during BPC 2009
PJ 2009;283:B23-B24

Science sessions

Debate: are medicines too expensive?
Who is to blame when the high cost of medicines prevents patients from receiving optimal treatment? This issue was debated by a speaker from Oxfam and one from The School of Pharmacy, University of London, during a BPC 2009 science session. Gareth Malson reports
PJ 2009;283:B25

Temozolomide: a pharmacist’s tale
The discovery of anticancer drug temozolomide and its turbulent journey to market was described by Malcolm Stevens, emeritus professor, University of Nottingham, and chief scientific officer, Pharminox, during the Academy of Pharmaceutical Sciences annual award lecture. Harriet Adcock reports
PJ 2009;283:B26

Pursuing effective anti-infectives
The emergence of drug-resistant infectious diseases is being met with a dearth of new anti-infective medicines — but there are new treatment options to be explored. Francesca Rivers reports from BPC 2009
PJ 2009;283:B27

Steroid sulphatase inhibitors: pushing the frontiers of cancer research
Discovery of a new class of anticancer agents saw professors Barry Potter and the late Michael Reed awarded the 2009 GlaxoSmithKline Industrial Achievement Award. Accepting the award, Professor Potter detailed the development of the new agents. Francesca Rivers reports
PJ 2009;283:B28-B29

Growth of pharmaceutical industry in current economic climate questionable
Personalised medicines, and disease modification and prevention, represent opportunities for the pharmaceutical industry. Nicola Cree reports
PJ 2009;283:B29

Methylene blue for Alzheimer’s disease
The serendipitous discovery that methylene blue may an effective treatment for Alzheimer’s disease was described by John Storey, senior lecturer, University of Aberdeen, in a session on the search for novel drugs. Nicola Cree reports
PJ 2009;283:B30

Thinking differently to drive innovation
Two speakers described how pharmaceutical companies are protecting their revenues through innovation. Harriet Adcock reports
PJ 2009;283:B31

 

Carl Alving, of the US Walter Reed Army Institute of Research, described recent progress in the development of a prophylactic vaccine against HIV and Nicol Keith, of the University of Glasgow, discussed new targets for cancer treatment. Francesca Rivers and Gareth Malson report

 

Nicola Cree reports on the aims and achievements of NICE and the development of companion diagnostic testing

 

Diabetes is fast becoming a global epidemic — and the therapeutic options available are developing almost as rapidly. With diabetic patients often taking several drugs, medicines management is key to tackling the disease. Francesca Rivers and Nicola Cree report from BPC 2009

 

Science abstracts

Science abstracts — review 2009
A sample of the work reported in the science sessions at the British Pharmaceutical Conference is reviewed here by Joseph Chamberlain
PJ 2009;283:B38-B40